[关键词]
[摘要]
目的：评价Ahmed 青光眼阀植入术治疗玻璃体手术后继发性青光眼的临床疗效。
方法：回顾分析在我院眼科应用Ahmed青光眼阀植入术治疗玻璃体手术后继发性青光眼患者23例23眼。
结果：患者术后平均随访29±3.7mo，术前平均眼压48.79±7.12mmHg，手术后24mo时平均眼压23.28±10.53mmHg，与术前眼压相比明显降低，具有显著性统计学差异(P<0.05)； 术后1mo时，手术成功率82.6%，随访12、24mo时手术成功率分别为65.2%、52.2%。
结论：采用Ahmed青光眼阀植入术治疗玻璃体手术后的继发性青光眼是比较有效和相对安全的治疗方法。
[Key word]
[Abstract]
AIM:To evaluate the outcome of Ahmed glaucoma valve implantation on treating glaucoma secondary to vitrectomy surgeries.
METHODS:Twenty-three eyes in 23 patients from our hospital treated with Ahmed valve implantations for their glaucoma secondary to vitrectomy surgeries were enrolled and their data was retrospectively analyzed.
RESULTS:The average following-up was 29±3.7mo. Before implantations, the mean intraocular pressure(IOP)was 48.79±7.12mmHg. After 24mo of operations the mean IOP was 23.28±10.53mmHg, and there was significant difference compared with that pre-operation(P<0.05). at 1,12 and 24mo after operations, success rate of the implantation was 82.6%, 65.2% and 52.2%, respectively.
CONCLUSION:Ahmed valve implantation is an effective and relatively safe method for the treatment of glaucoma secondary to vitrectomy surgeries.
[中图分类号]
[基金项目]
重庆市卫计委科研课题资助项目(No.2011-2-326)
